PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Tuesday reported a loss of $59.9 million in its first quarter.
The Pleasanton, California-based company said it had a loss of 50 cents per share.
The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 46 cents per share.
The life science technology company posted revenue of $141 million in the period, which also missed Street forecasts. Six analysts surveyed by Zacks expected $142 million.
10x Genomics expects full-year revenue in the range of $670 million to $690 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TXG at https://www.zacks.com/ap/TXG
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
